| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |